In prior works, HDAC inhibitors have shown the ability to exert cytostatic effects on cancer cells, as well as lead to apoptosis and differentiation through mechanisms that involve modifications of histone acetylation and chromatin remodeling [11, 16]. This evidence concerns the gene HDAC9 and cancer.